Melatonin

non-nutrient_non-botanical

Melatonin is a naturally occurring hormone produced primarily by the pineal gland in the brain. It plays a central role in regulating the circadian rhythm, which acts as the body's internal clock for sleep-wake cycles. Its production is sensitive to light; levels typically rise in the evening as darkness falls to promote sleepiness and decrease in the morning with light exposure. When used as a supplement, melatonin helps address various sleep disturbances by mimicking these natural signals. It assists in adjusting the internal clock, which may make it easier to fall asleep and improve overall sleep quality, particularly when natural rhythms are disrupted. It is also believed to have mild antioxidant properties. Melatonin is available in multiple forms, including tablets, capsules, and liquids, and is a common choice for managing jet lag, shift work sleep disorder, or occasional insomnia. Its effectiveness comes from its role in signaling the start of night to the brain, facilitating a smoother transition into sleep.

Natural sources
Pineal gland (human body)CherriesCornOatsRiceTomatoesWalnutsAlmonds

No public comparison lists found.

Optimal Dosage
Minimum1 mg
Maximum5 mg
Safety & Toxicity
Toxicity Threshold5000 mg
Toxicity EffectDrowsiness, confusion, dizziness
5 safety notes
  • Do not drive or operate heavy machinery after taking melatonin.
  • Consult a healthcare professional before use if pregnant, nursing, or have a medical condition (e.g., autoimmune disease, depression, seizure disorder).
  • Avoid alcohol when taking melatonin.
  • May affect blood sugar levels, caution for individuals with diabetes.
  • May affect blood pressure, caution for individuals with hypertension or hypotension.
Goals
Sleep Support
Impact
High effect
Typical dose:0.3–5 mg
Melatonin signals biological night and can help in certain circadian rhythm problems. Its usefulness differs from treating persistent difficulty sleeping, and evidence does not support it as a general treatment for chronic insomnia. Timing matters, more is not necessarily better, and long-term safety is not well established.

Study evidence

181 studies

Melatonin can help some people fall asleep sooner and modestly improve sleep, especially when sleep timing is delayed or in selected older adults. Benefits depend on the sleep problem and formulation; it does not consistently improve adult chronic insomnia or nighttime awakenings.

View goal
Testosterone Support
Impact
High effect
Typical dose:0.3–3 mg
The majority of daily testosterone release occurs during sleep. Melatonin supplementation can normalize circadian rhythms and improve sleep architecture, directly addressing a common and potent cause of suppressed testosterone levels. Quality sleep is essential for a healthy hormonal profile.

Study evidence

6 studies

The supplied research does not support Melatonin as a way to raise testosterone. Studies in men generally found unchanged testosterone, while a reduction reported in women with polycystic ovary syndrome concerns a different hormonal condition and does not establish harm in men.

View goal
Anti-Aging
Impact
Situational effect
Typical dose:0.3–3 mg
Natural melatonin production declines with age, disrupting circadian rhythms. Low-dose supplementation is highly effective for restoring a healthy sleep-wake cycle. While it is also a potent antioxidant, its primary, clinically-validated benefit is as a chronobiotic, making it most suitable for individuals with specific sleep challenges rather than a universal anti-aging supplement.

Study evidence

6 studies

Melatonin has promising effects on some oxidative-stress markers and selected skin or fertility outcomes, but these are not evidence that it slows aging overall. Much of the anti-aging rationale comes from animal research, specialized populations, or combined topical and oral treatments.

View goal
Brain Health
Impact
Situational effect
Typical dose:0.5–3 mg
High-quality sleep is non-negotiable for brain health, as it's when the brain clears metabolic waste and solidifies memories. Melatonin can help normalize sleep patterns, improving sleep onset and quality, which indirectly enhances next-day mental clarity and performance.

Study evidence

29 studies

Melatonin may modestly improve cognition in some older adults with cognitive impairment, but results are inconsistent. Evidence from these patients and specialized medical settings does not establish that melatonin protects a healthy brain or prevents dementia in the general population.

View goal
General Health
Impact
Situational effect
Typical dose:0.5–3 mg
Melatonin is a hormone that regulates the sleep-wake cycle. It is not a sedative but rather a chronobiotic agent. Low doses are highly effective for helping to align the body's circadian rhythm with a new time zone or work schedule, thereby improving sleep onset and quality.

Study evidence

69 studies

Melatonin can help with jet lag and some sleep problems, but broader general-health benefits are not consistently demonstrated. Effects vary by condition, and research on quality of life, fatigue, and disease outcomes includes substantial null findings alongside benefits in selected groups.

View goal
Immunity
Impact
Situational effect
Typical dose:0.5–5 mg
Beyond regulating sleep-wake cycles, melatonin has direct immunomodulatory effects. It can reduce the excessive inflammation and oxidative stress seen in severe infections (e.g., cytokine storm), making it a valuable tool for managing the body's response during illness.

Study evidence

10 studies

Melatonin can influence immune activity and reduce some inflammatory signals, but this does not establish that it broadly strengthens immunity. Human vaccine research shows selective changes in immune responses, while evidence for preventing everyday infections remains unestablished in the supplied research.

View goal
Showing 6 of 7 goals

Studies

Research connections will load here.
Interactions
Sources

Up to five highest-ranked published examples per goal. Study counts and charts include all published studies for the connection.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support
  2. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support
  3. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support
  4. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support
  5. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support
  6. Melatonin potentiates testosterone-induced suppression of luteinizing hormone secretion in normal men.
    Anderson RA; Lincoln GA; Wu FC · Human reproduction (Oxford, England) · 1994
    Randomized trial12 participantsTestosterone Support
  7. Effect of melatonin supplementation on cardiometabolic risk factors, oxidative stress and hormonal profile in PCOS patients: a systematic review and meta-analysis of randomized clinical trials.
    Ziaei S; Hasani M; Malekahmadi M; Daneshzad E; Kadkhodazadeh K; Heshmati J · Journal of ovarian research · 2024
    Meta-analysis6 studies pooledTestosterone Support
  8. Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome.
    Jamilian M; Foroozanfard F; Mirhosseini N; Kavossian E; Aghadavod E; Bahmani F; Ostadmohammadi V; Kia M; Eftekhar T; Ayati E; Mahdavinia M; Asemi Z · Frontiers in endocrinology · 2020
    Randomized trial56 participantsTestosterone Support
  9. A pharmacological dose of melatonin increases PRL levels in males without altering those of GH, LH, FSH, TSH, testosterone or cortisol.
    Waldhauser F; Lieberman HR; Lynch HJ; Waldhauser M; Herkner K; Frisch H; Vierhapper H; Waldhäusl W; Schemper M; Wurtman RJ · Neuroendocrinology · 1987
    Clinical trial24 participantsTestosterone Support
  10. Melatonin administered in the afternoon decreases next-day luteinizing hormone levels in men: lack of antagonism by flumazenil.
    Luboshitzky R; Shen-Orr Z; Shochat T; Herer P; Lavie P · Journal of molecular neuroscience : MN · 2000
    Randomized trial6 participantsTestosterone Support
  11. Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.
    Shang Y; Song N; He R; Wu M · Advances in nutrition (Bethesda, Md.) · 2024
    Meta-analysis2,617 participants20 studies pooledAnti-Aging
  12. Lipidomic and Instrumental Evaluation of a Melatonin-Based In & Out Strategy Versus Topical Treatment in Skin Aging: A Randomized Prospective Trial.
    Colombo F; Alfano S; Milani M · Metabolites · 2025
    Randomized trial39 participantsAnti-Aging
  13. Melatonin supplementation attenuates cuproptosis and ferroptosis in aging cumulus and granulosa cells: potential for improving IVF outcomes in advanced maternal age.
    Tsui KH; Li CJ; Lin LT · Reproductive biology and endocrinology : RB&E · 2024
    Cohort study161 participantsAnti-Aging
  14. Melatonin and healthy aging.
    Cardinali DP · Vitamins and hormones · 2021
    Narrative reviewAnti-Aging
  15. Clinical Studies Using Topical Melatonin.
    Greco G; Di Lorenzo R; Ricci L; Di Serio T; Vardaro E; Laneri S · International journal of molecular sciences · 2024
    Narrative reviewAnti-Aging
  16. Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
    Terao I; Kodama W · Journal of Alzheimer's disease : JAD · 2024
    Meta-analysis4,599 participants10 studies pooledBrain Health
  17. Melatonin for sleep and cognitive outcomes in older adults with cognitive impairment: a meta-analysis of randomised controlled trials.
    Mdluli NT; Banda KJ; Chang YC · Age and ageing · 2025
    Meta-analysis516 participants10 studies pooledBrain Health
  18. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial.
    Wade AG; Farmer M; Harari G; Fund N; Laudon M; Nir T; Frydman-Marom A; Zisapel N · Clinical interventions in aging · 2015
    Randomized trial80 participantsBrain Health
  19. Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule.
    Garofoli F; Asteggiano C; Minniti ML; Accorsi P; Albertini R; Angelini M; Aversa S; Ballante E; Cabini RF; Caporali C; Cociglio S; Franco V; Longo S; Malerba L; Materia V; Mazzocchi L; Naboni C; Palmisani M; Pullega C; Pisoni C; Preda L; Riboli A; Risso FM; Rognone E; Savini G; Simoncelli AM; Villani P; Tzialla C; Pinelli L; Fazzi E; Chiapparini L; Borgatti R; Ghirardello S; Pichiecchio A; Orcesi S · Journal of pineal research · 2026
    Randomized trial54 participantsBrain Health
  20. Efficacy and Safety of Melatonin in Migraine Prophylaxis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Abouelmagd ME; Aldemerdash MA; Khatatbeh AA; Osman ASA; Abbas A; Allam S; AlEdani EM; Aldemerdash A; Monteith TS · Current pain and headache reports · 2026
    Meta-analysis788 participants9 studies pooledBrain Health
  21. Melatonin for preventing and treating jet lag.
    Herxheimer A; Petrie KJ · The Cochrane database of systematic reviews · 2001
    Systematic review10 studies pooledGeneral Health
  22. Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life.
    Schroder CM; Malow BA; Maras A; Melmed RD; Findling RL; Breddy J; Nir T; Shahmoon S; Zisapel N; Gringras P · Journal of autism and developmental disorders · 2019
    Randomized trial125 participantsGeneral Health
  23. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials.
    Fatemeh G; Sajjad M; Niloufar R; Neda S; Leila S; Khadijeh M · Journal of neurology · 2022
    Meta-analysis23 studies pooledGeneral Health
  24. Efficacy of melatonin for chronic insomnia: Systematic reviews and meta-analyses.
    Choi K; Lee YJ; Park S; Je NK; Suh HS · Sleep medicine reviews · 2022
    Meta-analysis24 studies pooledGeneral Health
  25. Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial.
    Leerasiri P; Pariyaeksut P; Hengrasmee P; Asumpinwong C · International urogynecology journal · 2023
    Randomized trial60 participantsGeneral Health
  26. Exogenous melatonin boosts vaccine-induced immunity in individuals with high pre-existing influenza immunity.
    Oda K; Danko J; Villasante E; Bergmann-Leitner E; Lee R; Wijayalath W · Frontiers in immunology · 2025
    Randomized trialImmunity
  27. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis.
    Chojnacki C; Wisniewska-Jarosinska M; Walecka-Kapica E; Klupinska G; Jaworek J; Chojnacki J · Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2012
    Randomized trial60 participantsImmunity
  28. Pineal-opioid system interactions in the control of immunoinflammatory responses.
    Lissoni P; Barni S; Tancini G; Fossati V; Frigerio F · Annals of the New York Academy of Sciences · 1995
    Clinical trial130 participantsImmunity
  29. Influenza vaccine response is predicted by chronotype and differentially associated with pre- and post-vaccination sleep.
    Harrison EM; Lee RU; Porter CK; Isidean SD; Easterling AP; White L; Boulifard DA; DeTizio K; Liang Z; Sedegah M; Danko J; Glickman GL · Brain, behavior, & immunity - health · 2026
    Randomized trialImmunity
  30. Mechanisms and clinical evidence to support melatonin's use in severe COVID-19 patients to lower mortality.
    Tan DX; Reiter RJ · Life sciences · 2022
    Narrative review19 participantsImmunity
  31. The impact of oral melatonin on pain and anxiety reduction during venipuncture in pediatric patients: a double-blind randomized clinical trial.
    Rahafard S; Akbari Jokar Z; Hosseini SA; Alaee E · Annals of medicine and surgery (2012) · 2024
    Randomized trial202 participantsStress Relief
  32. Comparison of Effects of Melatonin and Gabapentin on Post Operative Anxiety and Pain in Lumbar Spine Surgery: A Randomized Clinical Trial.
    Javaherforooshzadeh F; Amirpour I; Janatmakan F; Soltanzadeh M · Anesthesiology and pain medicine · 2022
    Randomized trial90 participantsStress Relief
  33. Melatonin for pre- and postoperative anxiety in adults.
    Hansen MV; Halladin NL; Rosenberg J; Gögenur I; Møller AM · The Cochrane database of systematic reviews · 2015
    Meta-analysis774 participants12 studies pooledStress Relief
  34. Effects of melatonin intake on depression and anxiety in postmenopausal women: a systematic review and meta-analysis of randomised controlled trials.
    Demirhan Kayacik A; İlcioglu K · Archives of women's mental health · 2024
    Meta-analysis441 participants5 studies pooledStress Relief
  35. Premedication effect of melatonin on propofol induction dose for anesthesia, anxiety, orientation and sedation after abdominal surgery: a double-blinded randomized trial.
    Norouzi A; Fateh S; Modir H; Kamali A; Akrami L · Medical gas research · 2020
    Randomized trial88 participantsStress Relief